Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,824 | 40,288 | 54,735 | 66,162 | 42,497 |
| Marketable Securities | 83,424 | 99,139 | 85,795 | 87,822 | 124,526 |
| Receivables | 4,020 | 1,880 | 3,013 | 1,359 | 1,384 |
| TOTAL | $130,972 | $144,756 | $147,317 | $160,052 | $173,463 |
| Non-Current Assets | |||||
| PPE Net | 9,785 | 10,372 | 11,308 | 12,069 | 12,411 |
| Intangibles | 48,690 | 158,567 | 158,791 | 172,015 | 172,239 |
| Other Non-Current Assets | 1,929 | 1,929 | 2,002 | 1,935 | 1,935 |
| TOTAL | $60,404 | $170,868 | $172,101 | $186,019 | $186,585 |
| Total Assets | $191,376 | $315,624 | $319,418 | $346,071 | $360,048 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,607 | 6,566 | 5,792 | 5,538 | 4,940 |
| Accounts payable and accrued liabilities | 508 | 1,715 | 1,278 | 1,975 | 2,660 |
| Accrued Expenses | 14,897 | 19,455 | 17,845 | 21,275 | 19,424 |
| TOTAL | $24,012 | $27,736 | $24,915 | $28,788 | $27,024 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 33,282 | 51,519 | 75,351 | 85,826 | 85,188 |
| TOTAL | $33,282 | $51,519 | $75,351 | $85,826 | $85,188 |
| Total Liabilities | $57,294 | $79,255 | $100,266 | $114,614 | $112,212 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,564 | 9,410 | 9,070 | 8,560 | 8,344 |
| Common Shares | 143 | 9 | 132 | 127 | 124 |
| Retained earnings | -929,388 | -812,517 | -808,676 | -782,313 | -753,747 |
| Other shareholders' equity | 2,559 | 2,564 | 2,588 | 2,577 | 2,562 |
| TOTAL | $134,082 | $236,369 | $219,152 | $231,457 | $247,836 |
| Total Liabilities And Equity | $191,376 | $315,624 | $319,418 | $346,071 | $360,048 |